Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

National Database of Bone Metastases

NCT06367491 · tracked via the Priya Life Science Italy tracker
Phase
Observational
Started
2013-10-08
Last updated
2024-04-16

Condition(s) studied

Bone Metastases

Investigational drug(s) / intervention(s)

Registration in a database

Registration in a database: All patients with bone metastasis enrolled at the centre will be entered into the database and followed until death or interruption of follow-up for any another cause

Study summary

BDMO is an Italian multicentre, observational, prospective study that collects data from all patients with bone metastases referred to each participating centre, using an on-line software 'tailor-made' for data collection.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Radiological and/or histological diagnosis of bone metastasis from histologically established solid tumor * Males or females aged \>= 18 years * Informed consent Exclusion Criteria: * Not applicable

Primary outcome measure(s)

  • The establishment of a National Bone Metastasis Database at the IRCCS IRST — Up to 15 years

Trial sites (30)

FacilityCityRegionStatus
A.U.S.L. Imola Imola Bologna Recruiting
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Meldola FC Recruiting
Osp. "Sacro Cuore di Gesù" Gallipoli Lecce Not Yet Recruiting
Osp. S. Vincenzo - ASP Messina Taormina Messina Recruiting
Osp. Ramazzini di Carpi - AUSL Modena Carpi Modena Recruiting
P.O. "S. Maria delle Grazie" Pozzuoli Napoli Recruiting
Osp. degli Infermi Faenza Ravenna Recruiting
Ospedale Umberto I Lugo Ravenna Recruiting
Istituto Neurotraumatologico Italiano (INI) Grottaferrata Roma Recruiting
A.O.U. Ospedali Riuniti Ancona Italy Recruiting
Centro di Riferimento Oncologico - IRCCS CRO Aviano Italy Recruiting
A.O.U.C. Policlinico di Bari Osp."Giovanni XXIII" Bari Italy Recruiting
A.O. "S. Pio" Benevento Italy Recruiting
IRCCS Ist. Ortopedico Rizzoli Bologna Italy Recruiting
ASST Spedali Civili di Brescia Brescia Italy Recruiting
A.O. S. Croce e Carle Cuneo Italy Recruiting
A.O.U. "Arcispedale S. Anna" - AUSL Ferrara Ferrara Italy Recruiting
Ospedale Civile di Legnano - ASST Ovest Milanese Legnano Italy Recruiting
Fond. IRCCS Istituto Nazionale dei Tumori - INT Milan Italy Recruiting
A.O.R.N. "A. Cardarelli" Naples Italy Recruiting
Istituto Oncologico Veneto Padova Italy Recruiting
Fond. IRCCS Policlinico San Matteo Pavia Italy Recruiting
Osp. Guglielmo da Saliceto Piacenza Italy Recruiting
Osp. S. Maria delle Croci Ravenna Italy Recruiting
IRCCS Arcispedale S. Maria Nuova - A.O. Reggio Emilia Reggio Emilia Italy Recruiting
Ospedale degli Infermi Rimini Italy Recruiting
IRCCS Fond. Policlinico "A. Gemelli" - U.O.C. Oncologia Medica Roma Italy Recruiting
IRCCS Fond. Policlinico "A. Gemelli" - U.O.S. Senologia Medica / U.O.C. Ginecologia oncologica Roma Italy Recruiting
Ospedale di Treviglio - Caravaggio ASST Bergamo Ovest Treviglio Italy Recruiting
A.O.U.I. Verona Verona Italy Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06367491 on ClinicalTrials.gov ↗ ← All trials in Italy